Although the requirements for Stage 2 payments for meaningful use are not yet final, there is information to understand the challenges that organizations will face. In Stage 1, organizations could defer about half of the optional requirements; organizations were most likely to defer requirements related to patient engagement and coordinating care.

June 21, 2012 — SunTech Medical, a company specializing in non-invasive blood pressure measurement products and technologies, has been acquired by UK-based Halma plc, a safety, health and environmental technology group.

June 21, 2012 — Plans for a new study involving BioFreedom, the polymer-free drug-coated stent (DCS) from Biosensors, were announced  at EuroPCR by principal investigator Dr. Philip Urban, Hôpital de la Tour, Geneva.  

June 20, 2012 — More than 100,000 healthcare providers are using electronic health records (EHRs) that meet federal standards and have benefited from the Medicare and Medicaid Electronic Health Record Incentive Programs, the Centers for Medicare and Medicaid Services (CMS) and the Office of the National Coordinator for Health Information Technology (ONC) announced.

 

June 20, 2012 — Echocardiography is playing a key role in both the assessment and guidance of transcatheter aortic valve replacement (TAVR). Attendees at the American Society of Echocardiography’s 23rd Annual Scientific Sessions will have the opportunity to see this in action during a live TAVR procedure transmitted from Washington Hospital Center's hybrid cath lab.

June 20, 2012 – Siemens Healthcare announced the Somatom Definition Edge single-source computed tomography (CT) system has been approved for sale in the United States. It is the first single-source CT to use Siemens’ recently introduced Stellar Detector.

June 20, 2012 — In nuclear medicine and molecular imaging, small amounts of radioactive agents are administered to the patient to allow the physician to examine molecular processes within the body. These procedures are highly effective, safe and painless diagnostic tools that present physicians with a detailed view of what’s going on inside an individual’s body at the cellular level. The Society of Nuclear Medicine (SNM) and the SNM Technologist Section (SNMTS) recognize that the use of low levels of radiation in these procedures entails some possible risk.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now